Skip to main content

Wheezing clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for
  • Oral Bacterial Extract for the Prevention of Wheezing Lower Respiratory Tract Illness

    Sorry, in progress, not accepting new patients

    The primary objective of this study is to evaluate if Broncho-Vaxom® given to high risk infants for 10 days, monthly, for two consecutive years can increase time to occurrence of the first episode of wheezing lower respiratory tract illness (WLRI) during a three year observation period off therapy.

    Oakland, California and other locations

Last updated: